| SpectraBase Spectrum ID |
DnBQZcNbljM |
| Name |
N-Benzoyltryptamine |
| Classification |
Tryptamine designer drug |
| Copyright |
Copyright © 2024 DigiLab GmbH and Wiley-VCH GmbH. All Rights Reserved. |
| Exact Mass |
264.126263142 u |
| Formula |
C17H16N2O |
| InChI |
InChI=1S/C17H16N2O/c20-17(13-6-2-1-3-7-13)18-11-10-14-12-19-16-9-5-4-8-15(14)16/h1-9,12,19H,10-11H2,(H,18,20) |
| InChIKey |
KTEDBFKQSUUOQJ-UHFFFAOYSA-N |
| Ionization Type |
Electron Ionization (EI) |
| Molecular Weight |
264.328 g/mol |
| Nominal Mass |
264 u |
| Quality |
980 |
| Retention Index |
2736 |
| SMILES |
C=12C(NC=C2CCNC(C=2C=CC=CC2)=O)=CC=CC1 |
| SPLASH |
splash10-0006-1900000000-1023c32bb0a27765859d |
| Source of Spectrum |
DigiLab GmbH (C) 2024 |
| Synonyms |
Tryptamine,N-benzoyl
N-(2-(1H-indol-3-yl)ethyl)benzamide |
| Technique |
GC/MS |
| Wiley ID |
DD2024_007732 |
![3-[2-(BENZOYLAMINO)-ETHYL]-INDOLE](/api/spectrum/DnBQZcNbljM/structure.png?h=300&w=458 "3-[2-(BENZOYLAMINO)-ETHYL]-INDOLE")
